Fatigue in long-term Hodgkin's disease survivors:: A follow-up study

被引:100
作者
Hjermstad, MJ
Fosså, SD
Oldervoll, L
Holte, H
Jacobsen, AB
Loge, JH
机构
[1] Ullevaal Univ Hosp, Dept Oncol, N-0407 Oslo, Norway
[2] Univ Oslo, Dept Behav Sci Med, Oslo, Norway
[3] Norwegian Radium Hosp, Dept Med Oncol, Oslo, Norway
[4] Norwegian Radium Hosp, Dept Clin Res, Oslo, Norway
[5] Norwegian Univ Sci & Technol, Fac Med, Dept Clin & Mol Med, N-7034 Trondheim, Norway
关键词
D O I
10.1200/JCO.2005.09.936
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To describe total fatigue (TF) and chronic fatigue (CF) in 476 long-term Hodgkin's disease survivors (HDSs). The development in CIF over time was explored in 280 of the patients who had also been assessed 8 years earlier. Patients and Methods In 2003, the Fatigue Questionnaire was mailed to 610 successfully treated HDSs at the Norwegian Radium Hospital from 1971 to 1997. Mean TF scores and occurrence of CIF were compared with general population (GP) values. Results Four hundred seventy-six complete forms (81%) were received (median age, 46 years; 56% median follow-up time, 195 months). There was a positive association between age and TF (p < .05) whereas presence of B symptoms at diagnosis and treatment before 1980 were associated with CF. Mean TF scores were elevated in HDSs compared with the GP (mean TF score, 14.6; 95% Cl, 14.1 to 15.7 v 12.1; 95% Cl, 11.9 to 12.3, respectively; P < .001), as was the proportion of persons with CF (30% v 11%, respectively; odds ratio = 3.6; P < .001). The 70 patients with CF 8 years earlier still reported higher TF at follow-up than the 210 patients without CF at the previous assessment (mean TF score, 17.0; 95% Cl, 15.6 to 18.3 v 13.1; 95% Cl, 12.9 to 14.1, respectively; P < .001). Significantly more patients with persisting CF had B symptoms at diagnosis compared with patients who had recovered (P = .05). No significant association with treatment modality and intensity was found. Conclusion Fatigue remains a major complaint in HDSs several years after treatment, but the association between treatment and fatigue still remains unclear. Many HDSs may recover from CF, particularly patients without B symptoms at diagnosis.
引用
收藏
页码:6587 / 6595
页数:9
相关论文
共 47 条
[1]  
Abrahamsen AF, 1996, ANN ONCOL, V7, P145
[2]  
ABRAHAMSEN AF, 1981, SCAND J HAEMATOL, V26, P306
[3]   Hodgkin's disease in a national and hospital population: Trends over 20 years [J].
Abrahamsen, AF ;
Egeland, T ;
Hansen, S ;
Langholm, R ;
Holte, H ;
Kvaloy, S .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (14) :2380-2383
[4]   Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy [J].
Adams, MJ ;
Lipsitz, SR ;
Colan, SD ;
Tarbell, NJ ;
Treves, ST ;
Diller, L ;
Greenbaum, N ;
Mauch, P ;
Lipshultz, SE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3139-3148
[5]   Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].
Aleman, BMP ;
van den Belt-Dusebout, AW ;
Klokman, WJ ;
van't Veer, MB ;
Bartelink, H ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439
[6]   PSYCHOSOCIAL OUTCOMES OF CANCER - A COMPARATIVE-ANALYSIS OF HODGKINS-DISEASE AND TESTICULAR CANCER [J].
BLOOM, JR ;
FOBAIR, P ;
GRITZ, E ;
WELLISCH, D ;
SPIEGEL, D ;
VARGHESE, A ;
HOPPE, R .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :979-988
[7]   Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors [J].
Cella, D ;
Davis, K ;
Breitbart, W ;
Curt, G .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3385-3391
[8]   DEVELOPMENT OF A FATIGUE SCALE [J].
CHALDER, T ;
BERELOWITZ, G ;
PAWLIKOWSKA, T ;
WATTS, L ;
WESSELY, S ;
WRIGHT, D ;
WALLACE, EP .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (02) :147-153
[9]   CONTRASTING NEUROENDOCRINE RESPONSES IN DEPRESSION AND CHRONIC FATIGUE SYNDROME [J].
CLEARE, AJ ;
BEARN, J ;
ALLAIN, T ;
MCGREGOR, A ;
WESSELY, S ;
MURRAY, RM ;
OKEANE, V .
JOURNAL OF AFFECTIVE DISORDERS, 1995, 34 (04) :283-289
[10]  
Cohen J., 1988, STAT POWER ANAL BEHA